Ulcerative Colitis

We are currently enrolling for several Ulcerative Colitis trials. Our clinical research staff will collaborate with our physicians to determine which trial is best for you.

-We have a clinical trial for individuals taking Infliximab therapy (Remicade, Inflectra, or Remsima). You may qualify for participation if you:

  • Are between 18 and 75 years old
  • Have had a positive histological diagnosis of active ulcerative colitis for more than 4 months
  • Are currently taking Infliximab (Remicade, Inflectra, or Remsima) and still have frequent stools or rectal bleeding
  • Are willing to participate in the study, complete assessments and attend scheduled clinical visits, and
  • Satisfy all eligibility requirements

There may be additional qualifications. Please contact our Research Team to learn more! (616) 328-5344

 

-We also have a clinical trial for males and females between 18 to 75 years of age with Moderately to Severely Active Ulcerative Colitis. You may qualify for participation if you:

  • Demonstrated an inadequate response to, loss of response to, or intolerance to corticosteroids, immunosuppressants, and/or biologic therapies
  • Are willing to participate in the study, complete assessments and attend scheduled clinical visits, and
  • Satisfy all eligibility requirements

There may be additional qualifications. Please contact our Research Team to learn more! (616) 328-534